Coordinate depression of bradykinin receptor recycling and microtubule- dependent transport by taxol

S. F. Hamm-Alvarez, B. E. Alayof, H. M. Himmel, P. Y. Kim, A. L. Crews, H. C. Strauss, Michael Sheetz

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Significant cardiovascular side effects have limited the use of taxol as an anticancer drug. A link between decreased plasma membrane dynamics and taxol has been implied because taxol can inhibit intracellular vesicle movements. Reduced membrane recycling caused by taxol could inhibit agonist- evoked Ca2+ signaling within endothelial cells, resulting in endothelium- dependent vasodilation. Bradykinin and ATP are two agonists that evoke Ca2+ transients in endothelial cells. Since the bradykinin receptor-agonist complex is internalized and recycled whereas the ATP agonist-receptor complex is not, we expected that a taxol inhibition of recycling would decrease bradykinin but not ATP receptor activity. We found that taxol depresses (i) the frequency (to 41% of control) and velocity (to 55% of control) of microtubule-dependent vesicle transport and (ii) bradykinin-evoked cytosolic Ca2+ transients (to 76% of control) in bovine aortic endothelial cells. In studying bradykinin receptor desensitization, which reflects receptor recycling, we demonstrate that taxol inhibits bradykinin-evoked Ca2+ transients by 50%. Taxol did not significantly alter ATP-evoked Ca2+ transients in either single-exposure or desensitization experiments. We suggest that taxol's reduction of bradykinin-evoked Ca2+ transients is due to altered microtubule-dependent membrane recycling. This report describes taxol's ability to alter plasma membrane composition through effects on vesicle transport and membrane trafficking pathways. This finding provides a possible mechanism by which taxol can substantially alter cardiovascular function.

Original languageEnglish (US)
Pages (from-to)7812-7816
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume91
Issue number16
DOIs
StatePublished - Aug 10 1994
Externally publishedYes

Fingerprint

Bradykinin Receptors
Paclitaxel
Microtubules
Bradykinin
Purinergic P2 Receptors
Transport Vesicles
Endothelial Cells
Membranes
Adenosine Triphosphate
Cell Membrane
Recycling
Vasodilation
Endothelium

ASJC Scopus subject areas

  • General

Cite this

Coordinate depression of bradykinin receptor recycling and microtubule- dependent transport by taxol. / Hamm-Alvarez, S. F.; Alayof, B. E.; Himmel, H. M.; Kim, P. Y.; Crews, A. L.; Strauss, H. C.; Sheetz, Michael.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 91, No. 16, 10.08.1994, p. 7812-7816.

Research output: Contribution to journalArticle

Hamm-Alvarez, S. F. ; Alayof, B. E. ; Himmel, H. M. ; Kim, P. Y. ; Crews, A. L. ; Strauss, H. C. ; Sheetz, Michael. / Coordinate depression of bradykinin receptor recycling and microtubule- dependent transport by taxol. In: Proceedings of the National Academy of Sciences of the United States of America. 1994 ; Vol. 91, No. 16. pp. 7812-7816.
@article{71a2e1b9678641c9873ad7c8eff233c9,
title = "Coordinate depression of bradykinin receptor recycling and microtubule- dependent transport by taxol",
abstract = "Significant cardiovascular side effects have limited the use of taxol as an anticancer drug. A link between decreased plasma membrane dynamics and taxol has been implied because taxol can inhibit intracellular vesicle movements. Reduced membrane recycling caused by taxol could inhibit agonist- evoked Ca2+ signaling within endothelial cells, resulting in endothelium- dependent vasodilation. Bradykinin and ATP are two agonists that evoke Ca2+ transients in endothelial cells. Since the bradykinin receptor-agonist complex is internalized and recycled whereas the ATP agonist-receptor complex is not, we expected that a taxol inhibition of recycling would decrease bradykinin but not ATP receptor activity. We found that taxol depresses (i) the frequency (to 41{\%} of control) and velocity (to 55{\%} of control) of microtubule-dependent vesicle transport and (ii) bradykinin-evoked cytosolic Ca2+ transients (to 76{\%} of control) in bovine aortic endothelial cells. In studying bradykinin receptor desensitization, which reflects receptor recycling, we demonstrate that taxol inhibits bradykinin-evoked Ca2+ transients by 50{\%}. Taxol did not significantly alter ATP-evoked Ca2+ transients in either single-exposure or desensitization experiments. We suggest that taxol's reduction of bradykinin-evoked Ca2+ transients is due to altered microtubule-dependent membrane recycling. This report describes taxol's ability to alter plasma membrane composition through effects on vesicle transport and membrane trafficking pathways. This finding provides a possible mechanism by which taxol can substantially alter cardiovascular function.",
author = "Hamm-Alvarez, {S. F.} and Alayof, {B. E.} and Himmel, {H. M.} and Kim, {P. Y.} and Crews, {A. L.} and Strauss, {H. C.} and Michael Sheetz",
year = "1994",
month = "8",
day = "10",
doi = "10.1073/pnas.91.16.7812",
language = "English (US)",
volume = "91",
pages = "7812--7816",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "16",

}

TY - JOUR

T1 - Coordinate depression of bradykinin receptor recycling and microtubule- dependent transport by taxol

AU - Hamm-Alvarez, S. F.

AU - Alayof, B. E.

AU - Himmel, H. M.

AU - Kim, P. Y.

AU - Crews, A. L.

AU - Strauss, H. C.

AU - Sheetz, Michael

PY - 1994/8/10

Y1 - 1994/8/10

N2 - Significant cardiovascular side effects have limited the use of taxol as an anticancer drug. A link between decreased plasma membrane dynamics and taxol has been implied because taxol can inhibit intracellular vesicle movements. Reduced membrane recycling caused by taxol could inhibit agonist- evoked Ca2+ signaling within endothelial cells, resulting in endothelium- dependent vasodilation. Bradykinin and ATP are two agonists that evoke Ca2+ transients in endothelial cells. Since the bradykinin receptor-agonist complex is internalized and recycled whereas the ATP agonist-receptor complex is not, we expected that a taxol inhibition of recycling would decrease bradykinin but not ATP receptor activity. We found that taxol depresses (i) the frequency (to 41% of control) and velocity (to 55% of control) of microtubule-dependent vesicle transport and (ii) bradykinin-evoked cytosolic Ca2+ transients (to 76% of control) in bovine aortic endothelial cells. In studying bradykinin receptor desensitization, which reflects receptor recycling, we demonstrate that taxol inhibits bradykinin-evoked Ca2+ transients by 50%. Taxol did not significantly alter ATP-evoked Ca2+ transients in either single-exposure or desensitization experiments. We suggest that taxol's reduction of bradykinin-evoked Ca2+ transients is due to altered microtubule-dependent membrane recycling. This report describes taxol's ability to alter plasma membrane composition through effects on vesicle transport and membrane trafficking pathways. This finding provides a possible mechanism by which taxol can substantially alter cardiovascular function.

AB - Significant cardiovascular side effects have limited the use of taxol as an anticancer drug. A link between decreased plasma membrane dynamics and taxol has been implied because taxol can inhibit intracellular vesicle movements. Reduced membrane recycling caused by taxol could inhibit agonist- evoked Ca2+ signaling within endothelial cells, resulting in endothelium- dependent vasodilation. Bradykinin and ATP are two agonists that evoke Ca2+ transients in endothelial cells. Since the bradykinin receptor-agonist complex is internalized and recycled whereas the ATP agonist-receptor complex is not, we expected that a taxol inhibition of recycling would decrease bradykinin but not ATP receptor activity. We found that taxol depresses (i) the frequency (to 41% of control) and velocity (to 55% of control) of microtubule-dependent vesicle transport and (ii) bradykinin-evoked cytosolic Ca2+ transients (to 76% of control) in bovine aortic endothelial cells. In studying bradykinin receptor desensitization, which reflects receptor recycling, we demonstrate that taxol inhibits bradykinin-evoked Ca2+ transients by 50%. Taxol did not significantly alter ATP-evoked Ca2+ transients in either single-exposure or desensitization experiments. We suggest that taxol's reduction of bradykinin-evoked Ca2+ transients is due to altered microtubule-dependent membrane recycling. This report describes taxol's ability to alter plasma membrane composition through effects on vesicle transport and membrane trafficking pathways. This finding provides a possible mechanism by which taxol can substantially alter cardiovascular function.

UR - http://www.scopus.com/inward/record.url?scp=0027941146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027941146&partnerID=8YFLogxK

U2 - 10.1073/pnas.91.16.7812

DO - 10.1073/pnas.91.16.7812

M3 - Article

C2 - 7914372

AN - SCOPUS:0027941146

VL - 91

SP - 7812

EP - 7816

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 16

ER -